DW

Dev Wankhede

Director Director DIN 07076375
DIN 07076375 First appointment Jan 2015 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2015
Shareholding value Locked Premium profile

About Dev Wankhede

Data last updated:

Dev Wankhede has 11 years in corporate governance. Formerly with 1 company, such as Anju Drug Chem Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07076375
Primary Designation Director
First Appointment 21 Jan 2015
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Anju Drug Chem Private Limited U24230MP2007PTC019925
Additional Director21 Jan 20152007Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Anju Drug Chem Private Limited
Premium access

Shareholding and investment profile for Dev Wankhede

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dev Wankhede

Dev Wankhede has 11 years in corporate governance. Formerly with 1 company, such as Anju Drug Chem Private Limited. Engaged in General Business. Contributes to corporate operations.

Dev Wankhede is associated with 0 companies as a director.

Dev Wankhede has expertise in General Business.

Dev Wankhede has 11 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available